The Uncertain Impact Cannabis Has On COVID-19 Highlights Need For Rescheduling
https://hightimes.com/health/uncertain-impact-cannabis-has-covid-19-highlights-need-rescheduling/
The Schedule I status of marijuana stunts Americas ability to contribute to worldwide cannabis research. In light of the recent COVID-19 pandemic, these limitations became that much more apparent.
Today, much of the world remains in the dark when it comes to understanding cannabis, according to Dr. Laszlo Mechtler, Medical Director of the Dent Neurological Institute in Buffalo, NY. Dr. Mechtler told High Times that most people, at best, have a rudimentary understanding of the plant and its benefits.
The medical professional, whose roles include chief of neuro-oncology at the Roswell Park Center Institute, credits media outlets like High Times for disseminating information. However, he said that a lack of research prohibits a robust flow of information to the public.
It is my opinion that much of this lack of understanding stems from the lack of research that has been done on cannabis, which is rooted in marijuanas classification as a Schedule I controlled substance by the federal government, said Dr. Mechtler.
*snip*